
Commentary|Videos|March 4, 2026
Dr Pearson on the Role of AI for Drug Development and Discovery
Author(s)Alexander T. Pearson, MD, PhD
Fact checked by: Kyle Doherty
Alexander T. Pearson, MD, PhD, discusses how AI can be used for oncologic drug discovery and development.
Advertisement
Alexander T. Pearson, MD, PhD, explains how AI is being used for cancer drug discovery and development. He notes that the technology is able to quickly process vast amounts of information to identify compounds that could potentially be effective against cancer. Previous studies have shown that AI models can reduce the time it takes to develop a molecule suitable for study in a clinical trial from years down to months or even days, Pearson concludes.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026
2
ADCs Reshape the Future of Lung Cancer Care: From Second-Line Therapy to Earlier Intervention
3
Daraxonrasib Monotherapy Elicits Meaningful Responses in Previously Treated, RAS-Mutated Pancreatic Cancer
4
FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinoma
5




















































